Giletti, Andrea <br/><br/>
Genetic markers in methotrexate treatments.  [electronic resource] 

 -  The pharmacogenomics journal  12 2018 
 - 689-703 p.  digital 
<br/><br/> Publication Type: Journal Article; Systematic Review 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/s41397-018-0047-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Clinical Decision-Making<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Methotrexate--administration & dosage<br/>Methylenetetrahydrofolate Reductase (NADPH2)--genetics<br/>Patient Selection<br/>Pharmacogenetics--methods<br/>Pharmacogenomic Testing<br/>Pharmacogenomic Variants<br/>Polymorphism, Genetic<br/>Precision Medicine--methods<br/>Predictive Value of Tests<br/>Reduced Folate Carrier Protein--genetics<br/>Risk Assessment<br/>Thymidylate Synthase--genetics